Clinical outcomes and healthcare expenditures in the real world with left ventricular assist devices – The CLEAR-LVAD study
Open Access
- 22 February 2021
- journal article
- research article
- Published by Elsevier BV in The Journal of Heart and Lung Transplantation
- Vol. 40 (5), 323-333
- https://doi.org/10.1016/j.healun.2021.02.010
Abstract
No abstract availableKeywords
Funding Information
- Abbott Laboratories
This publication has 18 references indexed in Scilit:
- Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy IntentJAMA Cardiology, 2020
- The Society of Thoracic Surgeons Intermacs 2019 Annual Report: The Changing Landscape of Devices and IndicationsThe Annals of Thoracic Surgery, 2020
- A Fully Magnetically Levitated Left Ventricular Assist Device — Final ReportThe New England Journal of Medicine, 2019
- Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 MonthsJournal of the American College of Cardiology, 2017
- Intrapericardial Left Ventricular Assist Device for Advanced Heart FailureThe New England Journal of Medicine, 2017
- Pump thrombosis in the Thoratec HeartMate II device: An update analysis of the INTERMACS RegistryThe Journal of Heart and Lung Transplantation, 2015
- Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist deviceThe Journal of Heart and Lung Transplantation, 2013
- Outcomes in Advanced Heart Failure Patients With Left Ventricular Assist Devices for Destination TherapyCirculation: Heart Failure, 2012
- Linking inpatient clinical registry data to Medicare claims data using indirect identifiersAmerican Heart Journal, 2009
- Use of a Continuous-Flow Device in Patients Awaiting Heart TransplantationThe New England Journal of Medicine, 2007